Idera Pharmaceuticals, Inc. (IDRA) Appoints James Geraghty as Chairman of the Board of Directors
7/10/2013 7:06:41 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced the appointment of James Geraghty to serve as a member of the Board of Directors and also as its Chairman. Mr. Geraghty has held a wide range of leadership positions during a 20-year career at Genzyme Corporation, including substantial experience overseeing product development, commercial launches, and strategic transactions. Mr. Geraghty also served as a Senior Vice President of Sanofi SA following its acquisition of Genzyme, and recently took on a role as an Entrepreneur-in-Residence at Third Rock Ventures.
Help employers find you! Check out all the jobs and post your resume.
comments powered by